Ramoda - Company finances
|
EUR
|
2021
From: 2021-06-17
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | - | - | 286,529 | 92,602 | 137,849 |
| Profit before tax | -533 | -634 | 17,103 | -9,021 | -7,323 |
| Net profit | -533 | -634 | 16,255 | -9,021 | -7,323 |
| Equity | -533 | -1,167 | 15,088 | -9,933 | -17,156 |
| Liabilities | - | 3,109 | 69,607 | 55,831 | 63,156 |
| Non-current assets | 0 | 1,175 | 1,175 | 1,175 | 1,175 |
| Current assets | 2,062 | 767 | 83,520 | 44,723 | 44,825 |
| Total assets | 2,062 | 1,942 | 84,695 | 45,898 | 46,000 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 218 | - | - |
|
Financial indicators
|
|||||
| Revenue change y/y | - | - | - | -67.7% | +48.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -25.8% | -32.6% | 19.2% | -19.7% | -15.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | 107.7% | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | 5.7% | -9.7% | -5.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | 6.0% | -9.7% | -5.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 4.6 | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Ramoda - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-04-09 | 2024-04-30 | 11.64 |
| 2024-04-08 | 2024-04-08 | 169.77 |
| 2024-04-03 | 2024-04-07 | 193.50 |
| 2024-03-01 | 2024-04-02 | 129.00 |
| 2024-02-01 | 2024-02-29 | 64.50 |
| 2024-01-03 | 2024-01-31 | 234.52 |
| 2023-12-01 | 2024-01-02 | 175.89 |
| 2023-11-03 | 2023-11-30 | 117.26 |
| 2023-10-03 | 2023-11-02 | 58.63 |
| 2023-09-01 | 2023-09-30 | 117.26 |
| 2023-08-01 | 2023-08-31 | 58.63 |
| 2023-07-03 | 2023-07-31 | 234.52 |
| 2023-06-01 | 2023-07-02 | 175.89 |
| 2023-05-04 | 2023-05-31 | 117.26 |
| 2023-05-02 | 2023-05-03 | 58.63 |
| 2023-04-03 | 2023-04-30 | 58.63 |
| 2023-03-01 | 2023-03-31 | 168.21 |
| 2023-02-07 | 2023-02-28 | 109.58 |
| 2023-02-01 | 2023-02-06 | 194.66 |
| 2023-01-03 | 2023-01-31 | 136.03 |
| 2022-12-08 | 2023-01-02 | 85.08 |
| 2022-12-01 | 2022-12-07 | 152.85 |
| 2022-11-03 | 2022-11-30 | 101.90 |
| 2022-10-03 | 2022-11-02 | 50.95 |
| 2022-09-01 | 2022-09-30 | 50.95 |
Ramoda - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Ramoda, MB (company code 305802726) is a small partnership engaged in the retail sale of pharmaceutical products. In 2025, the company generated EUR 137.8K in revenue and recorded a net loss of EUR 7.3K, corresponding to a negative profit margin of 5.3%. Revenue improved by 48.9% year on year from 2024, but it remained well below the 2023 level, when turnover reached EUR 286.5K and net profit was EUR 16.3K. The 2024 result marked a downturn, with revenue falling to EUR 92.6K and a net loss of EUR 9.0K. The 2025 balance sheet shows total assets of EUR 46.0K, equity of EUR -17.2K and liabilities of EUR 63.2K. Short-term assets accounted for EUR 44.8K of assets, while long-term assets were EUR 1.2K. Asset turnover stood at 3.00x, indicating that revenue was generated efficiently relative to the asset base. Return ratios should be interpreted cautiously because equity was negative in 2025.